According to Goldstein Research, SingaporePharmaceuticals market is expected to reach grow at a CAGR of 6.40%. Development in cost effective medical services and modern technology adaptation is driving the growth of pharmaceutical industry. It is expected by 2024, Singapore medical device market mayreach over USD 530 million. Singapore Pharmaceuticals market segmentation has beendoneon the basis of products and therapeutics. Over-the-counter drugs acquires largest market share and by 2024 it is expected to contribute 48% to total Singapore pharmaceutical industry. Singapore Pharmaceuticals market provides attractive opportunities to foreign investors as well as to local startups. Singapore government expenditure on healthcare has been growing and reached USD 13 billion in 2016. Singapore contribution in global pharmaceutical product manufacturing accounts for 10% of global contact lenses, 70% of microarray and 50% of thermal cyclers.
Market Segmentation
On the basis of our in-depth analysis, SingaporePharmaceuticals Market can be segmented as follows:
• Based on Products
o Over-the-counter (OTC) drugs
o Generic Drugs
o Patented Drugs

• Based on Therapeutics
o Cardiovascular Diseases
o Diabetes
o Respiratory Diseases
o Infectious Diseases
o Oncology
o Gastrointestinal Problems
o Central Nervous System (CNS) Disorders
o Other Diseases (Dermatology, Rheumatology)

“Singapore Pharmaceuticals Industry Analysis” contains detailed overview of the Singapore Pharmaceuticals market. On the basis of our in-depth analysis, market can be segmented in terms of market segmentation by products and therapeutics.
Further, for the in-depth analysis, Singapore Pharmaceuticals Market Report encompasses the industry growth drivers, market challenges, risk analysis, market attractiveness, BPS (Base Point Scale) analysis, Porter’s five force model and SWOT analysis. This market report also includes competitive outlook of some of the major players profiling of companies such asAmway, Novartis International AG, GlaxoSmithKline (GSK), Abbot Laboratories, Lonza, Merck Sharp &Dohme, Takeda, Roche Holding AG, Pfizer Inc., Raffles Medical Group Ltd., Wave Life Sciences, SphaeraPharma, Special Access Pharma, Pharmaskin, NCI Health, Melbourne Drugs,etc. The company profiles include business strategy, geographical revenue distribution, major information of the companies which encompasses business outlook, products, services and industries catered, financial analysis of the company and recent developments. Overall, the report represents the SingaporePharmaceuticals market trends along with market forecast that will help industry consultants, technology providers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.
Send us sample request @ https://www.goldsteinresearch.com/request-sample/singapore-pharmaceutical-market-outlook-2024-opportunity-assessment-and-demand-analysis-market-forecast-2016-2024

About Goldstein Research
Based in the US, Goldstein Research currently has a strong presence in the American and Asian countries. In the next five years, we strive to expand our reach to 50+ nations spanning across Europe, Asia and parts of the Middle East and Africa. We strive to realize a strong brand presence globally through our quality research and forecasting solutions.
Our mission is simple: to develop insightful business solutions, help our clients make powerful future decisions to keep them well ahead of the game which is the market, and leave a mark across businesses and communities through our well-defined ideas and clear cut forecasts. Our market research reports provide in-depth analysis of Singapore and regional variations along with competitors’ overview. Our analysts working on healthcare reports to help various tech-giants, tech start-ups and entry players to assess the current and upcoming business scenario. We believe in vigorous examination of the current market scenario and build around creative ideas and approaches that are most suitable to our clients’ needs and business agenda.
Contact us for more details
Steve Blade
(Global Sales Head)
USA: + 1-646-568-7747
Canada: 1-437-886-1181
UK: +44-203-318-6627
[email protected]
www.goldsteinresearch.com